• Sort Blog:
  • All
  • Malattie del viaggiatore
  • Patogenesi
  • Malnutrizione
  • Tossinfezion alimentari
  • Squilibri ormonali
  • Uncategorized
  • Malattie da prioni4
  • Rickettsie
  • Fattori di rischio
  • Malattie neurologiche
  • Malattie autoimmuni
  • Batteriologia
  • Malattie da prioni
  • Terapie antinfettive
  • Farmaci antinfiammatori
  • Malattie delle articolazioni
  • Malattie ortopediche
  • Micologia
  • Immunologia
  • Tossicodipendenza
  • Sepsi neonatale
  • inflammatory bowel disease (IBD)
  • Infezioni urinarie
  • Infezioni associate all'assistenza sanitaria
  • Veterinaria
  • Prevenzione
  • Sepsi
  • Febbre
  • Malattie dell'occhio
  • Parassitologia
  • Infezioni atipiche
  • Marcatori d'infezione
  • Varie
  • Terapie palliative
  • Virologia
  • Zoonosi
  • Problemi diagnostici
  • Microbioma
  • Farmacologia
  • Antibiotici
  • Test diagnostici
  • Trapianti d'organo o tessuti
  • Neoplasie
  • Eziologia
  • Micobatteriologia
  • Tossinfezioni alimentari
  • Tecnologia
  • Metagenomica
  • Malattie respiratorie
  • Avvisi ai lettori
  • Fagi
  • Intossicazione alimentare
  • Malattie Tropicali
  • Malattie infiammatorie
  • Ultime notizie
  • antimicotici
  • Genomica
  • Malattie Metaboliche
  • Nutrizione
  • Mal. a trasm. sessuale
  • Medicina ambientale
  • Semeiotica
  • Probiotici
  • Tossicologia
  • Linee guida - Raccomandazioni
  • Epidemie infettive
  • Eruzioni mucocutanee da infezione
  • Marcatore
  • Malattie cardiocircolatorie
  • Vaccinazioni
  • Prognosi delle infezioni
  • Malattie dermatologiche
  • Oculistica
  • Malformazioni congenite
  • Argomento generico
  • Disinfezione
  • Oncologia
  • Malattie genetiche
  • Malattie renali
  • Problemi metodologici
  • Necrologio
  • Flogosi acute o croniche
  • Malattie da infezione
  • Politica sanitaria

Effect of Oral Azithromycin vs Placebo on COVID-19 Symptoms in Outpatients With SARS-CoV-2 Infection: A Randomized Clinical Trial

Effect of Oral Azithromycin vs Placebo on COVID-19 Symptoms in Outpatients With SARS-CoV-2 Infection: A Randomized Clinical Trial.Oldenburg CE, Pinsky BA, Brogdon J, Chen C, Ruder K, Zhong L, Nyatigo F, Cook CA, Hinterwirth A, Lebas E, Redd T, Porco TC, Lietman TM, Arnold BF, Doan T.JAMA. 2021 Jul 16. doi: 10.1001/jama.2021.11517. Online ahead of print.PMID: 34269813

Fighting Antibiotic Resistance in Hospital-Acquired Infections: Current State and Emerging Technologies in Disease Prevention, Diagnostics and Therapy

Fighting Antibiotic Resistance in Hospital-Acquired Infections: Current State and Emerging Technologies in Disease Prevention, Diagnostics and Therapy. Avershina Ekaterina, Shapovalova Valeria, Shipulin German. Frontiers in Microbiology 2021,12,2044

URL=https://www.frontiersin.org/article/10.3389/fmicb.2021.707330

ABSTRACT=Rising antibiotic resistance is a global threat that is projected to cause more deaths than all cancers combined by 2050. In this review, we set to summarize the current state of antibiotic resistance, and to give an overview of the emerging technologies aimed to escape the pre-antibiotic era recurrence. We conducted a comprehensive literature survey of >150 original research and review articles indexed in the Web of Science using “antimicrobial resistance,” “diagnostics,” “therapeutics,” “disinfection,” “nosocomial infections,” “ESKAPE pathogens” as key words. We discuss the impact of nosocomial infections on the spread of multi-drug resistant bacteria, give an overview over existing and developing strategies for faster diagnostics of infectious diseases, review current and novel approaches in therapy of infectious diseases, and finally discuss strategies for hospital disinfection to prevent MDR bacteria spread.

Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices – United States, June 2021

Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices – United States, June 2021.Gargano JW, Wallace M, Hadler SC, Langley G, Su JR, Oster ME, Broder KR, Gee J, Weintraub E, Shimabukuro T, Scobie HM, Moulia D, Markowitz LE, Wharton M, McNally VV, Romero JR, Talbot HK, Lee GM, Daley MF, Oliver SE.MMWR Morb Mortal Wkly Rep. 2021 Jul 9;70(27):977-982. doi: 10.15585/mmwr.mm7027e2.PMID: 34237049 Free article.

AmpliCoV: Rapid Whole-Genome Sequencing Using Multiplex PCR Amplification and Real-Time Oxford Nanopore MinION Sequencing Enables Rapid Variant Identification of SARS-CoV-2

AmpliCoV: Rapid Whole-Genome Sequencing Using Multiplex PCR Amplification and Real-Time Oxford Nanopore MinION Sequencing Enables Rapid Variant Identification of SARS-CoV-2.Brinkmann A, Ulm SL, Uddin S, Förster S, Seifert D, Oehme R, Corty M, Schaade L, Michel J, Nitsche A.Front Microbiol. 2021 Jul 1;12:651151. doi: 10.3389/fmicb.2021.651151. eCollection 2021.PMID: 34276587 Free PMC article.

Acquisition of Tigecycline Resistance by Carbapenem-Resistant Klebsiella pneumoniae Confers Collateral Hypersensitivity to Aminoglycosides

Acquisition of Tigecycline Resistance by Carbapenem-Resistant Klebsiella pneumoniae Confers Collateral Hypersensitivity to Aminoglycosides.Chen HL, Jiang Y, Li MM, Sun Y, Cao JM, Zhou C, Zhang XX, Qu Y, Zhou TL.Front Microbiol. 2021 Jul 2;12:674502. doi: 10.3389/fmicb.2021.674502. eCollection 2021.PMID: 34276606 Free PMC article.

La Segreteria AMCLI effettua la chiusura il giorno 26 aprile 2024 in occasione del ponte del 25 aprile.